Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-008219

Global President TAVR & Surg sold 6,421 shares at $79.30 ($509,185)

  • Global President TAVR & Surg acquired 6,421 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wood Larry L · Global President TAVR & Surg

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-14 Exercise or conversion : show line 1 in the form 10b5-1 +6,421 $45.28 $290,722 220,214.71 D
2023-08-14 Sale : show line 2 in the form 10b5-1 −6,421 $79.30 $509,185 213,793.71 D
Open-market sales · 6,421 sh · avg $79.30 · $509,185

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-08-14 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −6,421 $45.28 2025-05-16 6,421 34,638 D
Loading xslF345X05/doc4.xml…